Regulator Suspects Cartel Behind PCR Bundling Tests


Indonesia’s Business Competition Supervisory Commission (KPPU) is investigating allegations of unfair business competition in the COVID-19 rapid test business involving polymerase chain reaction (PCR) tests. KPPU's Director of Economics Mulyawan Ranamanggala revealed unidentified parties wanting to profit from the PCR test. One of them is bundling or combining the service with a PCR test. "There are indications that they want to maximize profits," Mulyawan explained on Friday.

KPPU has identified two ways for PCR test providers in maximizing profits and causing unfair business competition, namely:

  1. A doctor's consultation. It will definitely increase almost twice the cost of the PCR test. As a result, the PCR test’s function shifts from tracing COVID-19 patients into a profit-oriented business.
  2. Providing express facilities to people who need fast PCR test results. The comparison between the speeds of test results from one laboratory to another creates unfair business competition. As a result, consumers have to pay more.

Start your free trial.

If you would like to get a 30-day free unlimited access to all of our insights, please click “Start free trial” button below. If you already have an account, please login.

What do subscribers receive?

As a subscriber, you’ll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Enjoy a 30-day free trial, on us. Feel free to contact us with any additional questions you have.